CAC
Cowen and Company’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-66,470
| Closed | -$3.98M | – | 605 |
|
|
2023
Q4 | $3.98M | Buy |
+66,470
| New | +$3.98M | 0.26% | 65 |
|
|
2023
Q1 | – | Sell |
-5,000
| Closed | -$259K | – | 551 |
|
|
2022
Q4 | $259K | Sell |
5,000
-14,000
| -74% | -$724K | 0.03% | 151 |
|
|
2022
Q3 | $501K | Buy |
19,000
+16,008
| +535% | +$422K | 0.05% | 118 |
|
|
2022
Q2 | $135K | Buy |
2,992
+1,762
| +143% | +$79.5K | 0.01% | 199 |
|
|
2022
Q1 | $62K | Buy |
+1,230
| New | +$62K | 0.01% | 257 |
|
|
2021
Q4 | – | Sell |
-57,889
| Closed | -$1.91M | – | 491 |
|
|
2021
Q3 | $1.91M | Buy |
57,889
+50,133
| +646% | +$1.65M | 0.09% | 98 |
|
|
2021
Q2 | $490K | Buy |
+7,756
| New | +$490K | 0.03% | 168 |
|